Teede HJ, Tay CT, Laven JJE et al (2023) Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab 108(10):2447–2469. https://doi.org/10.1210/clinem/dgad463
Article PubMed PubMed Central Google Scholar
Sadeghi HM, Adeli I, Calina D et al (2022) Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci 23(2)
Article CAS PubMed PubMed Central Google Scholar
Bahri Khomami M, Boyle JA, Tay CT et al (2018) Polycystic ovary syndrome and adverse pregnancy outcomes: Current state of knowledge, challenges and potential implications for practice. Clin Endocrinol (Oxf) 88(6):761–769. https://doi.org/10.1111/cen.13579
Siddiqui S, Mateen S, Ahmad R, Moin S (2022) A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet 39(11):2439–2473. https://doi.org/10.1007/s10815-022-02625-7
Article PubMed PubMed Central Google Scholar
Zavatta A, Parisi F, Mando C et al (2023) Role of inflammaging on the reproductive function and pregnancy. Clin Rev Allergy Immunol 64(2):145–160. https://doi.org/10.1007/s12016-021-08907-9
Choudhury AA, Devi Rajeswari V (2021) Gestational diabetes mellitus - a metabolic and reproductive disorder. Biomed Pharmacother 143:112183. https://doi.org/10.1016/j.biopha.2021.112183
Article CAS PubMed Google Scholar
Moon JH, Jang HC (2022) Gestational diabetes mellitus: diagnostic approaches and maternal-offspring complications. Diabetes Metab J 46(1):3–14. https://doi.org/10.4093/dmj.2021.0335
Article PubMed PubMed Central Google Scholar
Chaudhary S, Kulkarni A (2024) Metformin: Past, Present, and Future. Curr Diab Rep. https://doi.org/10.1007/s11892-024-01539-1
Dutta S, Shah RB, Singhal S et al (2023) Metformin: a review of potential mechanism and therapeutic utility beyond diabetes. Drug Des Devel Ther 17:1907–1932. https://doi.org/10.2147/DDDT.S409373
Article CAS PubMed PubMed Central Google Scholar
Lovvik TS, Carlsen SM, Salvesen O et al (2019) Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 7(4):256–266. https://doi.org/10.1016/S2213-8587(19)30002-6
Vanky E, Salvesen KA, Heimstad R et al (2004) Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 19(8):1734–1740. https://doi.org/10.1093/humrep/deh347
Article CAS PubMed Google Scholar
Nawaz FH, Khalid R, Naru T, Rizvi J (2008) Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome? J Obstet Gynaecol Res 34(5):832–837. https://doi.org/10.1111/j.1447-0756.2008.00856.x
Vanky E, Stridsklev S, Heimstad R et al (2010) Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 95(12):E448-455. https://doi.org/10.1210/jc.2010-0853
Article CAS PubMed Google Scholar
Nawaz FH, Rizvi J (2010) Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome. Gynecol Obstet Invest 69(3):184–189. https://doi.org/10.1159/000268051
Article CAS PubMed Google Scholar
Mowafi HEM (2012) The role of continuing metformin therapy during pregnancy in reduction of gestational diabetes and improving pregnancy outcome in women with polycystic ovary syndrome. Middle East Fertil Soc J. https://doi.org/10.1016/j.mefs.2011.04.002
Chiswick C, Reynolds RM, Denison F et al (2015) Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 3(10):778–786. https://doi.org/10.1016/S2213-8587(15)00219-3
Article CAS PubMed PubMed Central Google Scholar
Rotterdam EA-SPcwg (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41–47. https://doi.org/10.1093/humrep/deh098
Practice Committee of the American Society for Reproductive M (2015) Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril 103(6):e44-50. https://doi.org/10.1016/j.fertnstert.2015.03.019
Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539–553. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
Article CAS PubMed Google Scholar
Rashid R, Mir SA, Kareem O et al (2022) Polycystic ovarian syndrome-current pharmacotherapy and clinical implications. Taiwan J Obstet Gynecol 61(1):40–50. https://doi.org/10.1016/j.tjog.2021.11.009
Guevara-Ramirez P, Paz-Cruz E, Cadena-Ullauri S et al (2023) Molecular pathways and nutrigenomic review of insulin resistance development in gestational diabetes mellitus. Front Nutr 10
Article CAS PubMed PubMed Central Google Scholar
Khattab S, Mohsen IA, Aboul Foutouh I et al (2011) Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study. Gynecol Endocrinol 27(10):789–793. https://doi.org/10.3109/09513590.2010.540600
Article CAS PubMed Google Scholar
Thatcher SS, Jackson EM (2006) Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin. Fertil Steril 85(4):1002–1009. https://doi.org/10.1016/j.fertnstert.2005.09.047
Article CAS PubMed Google Scholar
Herman R, Kravos NA, Jensterle M et al (2022) Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport. Int J Mol Sci 23:(3). https://doi.org/10.3390/ijms23031264
Article CAS PubMed Central Google Scholar
Wartena R, Matjila M (2023) Polycystic ovary syndrome and recurrent pregnancy loss, a review of literature. Front Endocrinol (Lausanne) 14:1183060. https://doi.org/10.3389/fendo.2023.1183060
Matsuyama S, Whiteside S, Li SY (2024) Implantation and Decidualization in PCOS: Unraveling the Complexities of Pregnancy. Int J Mol Sci 25(2):1203. https://doi.org/10.3390/ijms25021203
Article CAS PubMed PubMed Central Google Scholar
Khattab S, Mohsen IA, Foutouh IA et al (2006) Metformin reduces abortion in pregnant women with polycystic ovary syndrome. Gynecol Endocrinol 22(12):680–684. https://doi.org/10.1080/09513590601010508
Article CAS PubMed Google Scholar
Begum MR, Khanam NN, Quadir E et al (2009) Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome. J Obstet Gynaecol Res 35(2):282–286. https://doi.org/10.1111/j.1447-0756.2008.00876.x
Article CAS PubMed Google Scholar
Mahmoud MM, Rashed LA, Soliman SA et al (2023) SGLT-2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory marke
留言 (0)